Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study.,The BMJ

当前位置： X-MOL 学术 › BMJ › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study.
The BMJ ( IF 93.6 ) Pub Date : 2020-04-28 , DOI: 10.1136/bmj.m997
Yongze Li ₁ , Di Teng ₂ , Xiaoguang Shi ₁ , Guijun Qin ₃ , Yingfen Qin ₄ , Huibiao Quan ₅ , Bingyin Shi ₆ , Hui Sun ₇ , Jianming Ba ₈ , Bing Chen ₉ , Jianling Du ₁₀ , Lanjie He ₁₁ , Xiaoyang Lai ₁₂ , Yanbo Li ₁₃ , Haiyi Chi ₁₄ , Eryuan Liao ₁₅ , Chao Liu ₁₆ , Libin Liu ₁₇ , Xulei Tang ₁₈ , Nanwei Tong ₁₉ , Guixia Wang ₂₀ , Jin-An Zhang ₂₁ , Youmin Wang ₂₂ , Yuanming Xue ₂₃ , Li Yan ₂₄ , Jing Yang ₂₅ , Lihui Yang ₂₆ , Yongli Yao ₂₇ , Zhen Ye ₂₈ , Qiao Zhang ₂₉ , Lihui Zhang ₃₀ , Jun Zhu ₃₁ , Mei Zhu ₃₂ , Guang Ning ₃₃ , Yiming Mu ₈ , Jiajun Zhao ₃₄ , Weiping Teng ₂ , Zhongyan Shan ₁

Affiliation

Department of Endocrinology and Metabolism and the Institute of Endocrinology, First Hospital of China Medical University, 155 Nanjing Bei Street, Shenyang, 110001, Liaoning, China.
Department of Endocrinology and Metabolism and the Institute of Endocrinology, First Hospital of China Medical University, 155 Nanjing Bei Street, Shenyang, 110001, Liaoning, China
Division of Endocrinology, Department of Internal Medicine, First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Department of Endocrinology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Department of Endocrinology, Hainan General Hospital, Haikou, Hainan, China.
Department of Endocrinology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shannxi, China.
Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Department of Endocrinology, Chinese PLA General Hospital, Beijing, China.
Department of Endocrinology, Southwest Hospital, Third Military Medical University, Chongqing, China.
Department of Endocrinology, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Department of Endocrinology, Cardiovascular and Cerebrovascular Disease Hospital of Ningxia Medical University, Yinchuan, Ningxia, P.R. China, 750004.
Department of Endocrinology and Metabolism, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Department of Endocrinology, First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Department of Endocrinology, Hohhot First Hospital, Hohhot, Inner Mongolia, China.
Department of Endocrinology and Metabolism, Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Research Centre of Endocrine and Metabolic Diseases, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Department of Endocrinology and Metabolism, Fujian Institute of Endocrinology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
Department of Endocrinology, First Hospital of Lanzhou University, Lanzhou, Gansu, China.
Department of Endocrinology and Metabolism, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Department of Endocrinology and Metabolism, First Hospital of Jilin University, Changchun, Jilin, China.
Department of Endocrinology, Shanghai University of Medicine and Health Science Affiliated Zhoupu Hospital, Shanghai, China.
Department of Endocrinology, First Hospital of An Hui Medical University, Hefei, Anhui, China.
Department of Endocrinology, First People's Hospital of Yunnan Province, Kunming, Yunnan, China.
Department of Endocrinology and Metabolism, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Department of Endocrinology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Department of Endocrinology and Metabolism, People's Hospital of Tibet Autonomous Region, Lhasa, Tibet, China.
Department of Endocrinology, Qinghai Provincial People's Hospital, Xining, Qinghai, China.
Zhejiang Provincial Centre for Disease Control and Prevention, Hangzhou, Zhejiang, China.
Department of Endocrinology and Metabolism, Affiliated Hospital of Guiyang Medical University, Guiyang, Guizhou, China.
Department of Endocrinology, Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Department of Endocrinology, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China.
Department of Endocrinology and Metabolism and the Institute of Endocrinology, Rui-Jin Hospital affiliated with Shanghai Jiao-Tong University School of Medicine, Shanghai, China.
Department of Endocrinology, Shandong Provincial Hospital affiliated with Shandong University, Jinan, Shandong, China.

OBJECTIVE To assess the prevalence of diabetes and its risk factors. DESIGN Population based, cross sectional study. SETTING 31 provinces in mainland China with nationally representative cross sectional data from 2015 to 2017. PARTICIPANTS 75 880 participants aged 18 and older-a nationally representative sample of the mainland Chinese population. MAIN OUTCOME MEASURES Prevalence of diabetes among adults living in China, and the prevalence by sex, regions, and ethnic groups, estimated by the 2018 American Diabetes Association (ADA) and the World Health Organization diagnostic criteria. Demographic characteristics, lifestyle, and history of disease were recorded by participants on a questionnaire. Anthropometric and clinical assessments were made of serum concentrations of fasting plasma glucose (one measurement), two hour plasma glucose, and glycated haemoglobin (HbA1c). RESULTS The weighted prevalence of total diabetes (n=9772), self-reported diabetes (n=4464), newly diagnosed diabetes (n=5308), and prediabetes (n=27 230) diagnosed by the ADA criteria were 12.8% (95% confidence interval 12.0% to 13.6%), 6.0% (5.4% to 6.7%), 6.8% (6.1% to 7.4%), and 35.2% (33.5% to 37.0%), respectively, among adults living in China. The weighted prevalence of total diabetes was higher among adults aged 50 and older and among men. The prevalence of total diabetes in 31 provinces ranged from 6.2% in Guizhou to 19.9% in Inner Mongolia. Han ethnicity had the highest prevalence of diabetes (12.8%) and Hui ethnicity had the lowest (6.3%) among five investigated ethnicities. The weighted prevalence of total diabetes (n=8385) using the WHO criteria was 11.2% (95% confidence interval 10.5% to 11.9%). CONCLUSION The prevalence of diabetes has increased slightly from 2007 to 2017 among adults living in China. The findings indicate that diabetes is an important public health problem in China.

更新日期：2020-04-28

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文